News

Reader based multiplex lateral flow assays are opening new opportunities for biomarker signatures, structured data capture and algorithmic interpretation. This article explores how candidate markers can be assessed, translated into lateral flow and developed into reliable diagnostic systems with the reader, software, manufacture and regulatory pathway considered from the start.

Fleet Bioprocessing is attending Med-Tech Expo 2026 at the NEC Birmingham on Wednesday 3rd June. We look forward to meeting researchers and industry partners working in diagnostics, assay technologies and healthcare innovation.

Fleet Bioprocessing will be attending Sensors for Health 2026 at Swansea University on 29 April. The event brings together researchers and industry working in health related sensor development, diagnostics and translation.